Revenue Growth (YoY)
Updated 10h ago
Sector Performance
12th percentileXRAY
0.1%
Sector Median
7.9%
Sector Avg
11.7%
Deep Analysis
Revenue growth year-over-year (YoY) compares a company’s current revenue to the same period one year ago; a 0.1% increase means revenue barely changed.
This 0.1% growth places the company well below its sector peers, which have a median YoY growth of 7.9%, and it sits in the 12th percentile among those peers. The trend direction is listed as N/A for the last eight quarters, and both the YoY and quarter-over-quarter changes are also N/A — only a single historical value of 0.1% is available. Because the current level is extremely low relative to the sector and there is no trend data to assess momentum, the combination implies a risk of revenue stagnation with no clear opportunity for acceleration from the recent past. This low, flat growth does not contradict the overall NEUTRAL verdict, as the metric simply shows the company is underperforming its peers without indicating a dramatic decline or turnaround.
Frequently Asked Questions
What does the Revenue Growth (YoY) tell investors about XRAY?
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
How is the Revenue Growth (YoY) calculated?
Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.
Who are XRAY's closest peers by Revenue Growth (YoY)?
The closest peers by Revenue Growth (YoY) include: COP (-4.6%), CCI (-4.8%), EMN (-4.9%), IPG (-5.1%), LEN (-5.2%).
The Formula
(Revenue_t - Revenue_t-4) / Revenue_t-4
Why It Matters
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
Master XRAY's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full XRAY research report →XRAY
0.1%
Sector Median
7.9%
Sector Avg
11.7%
How XRAY's Revenue Growth (YoY) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.